Today, the General Counsel of Nu Skin (NYSE: NUS), Matthew Dorny, sold shares of NUS for $959.5K.
See today’s analyst top recommended stocks >>
Based on Nu Skin’s latest earnings report for the quarter ending March 31, the company posted quarterly revenue of $616 million and quarterly net profit of $35.54 million. In comparison, last year the company earned revenue of $499 million and had a net profit of $27.49 million. The company has a one-year high of $76.24 and a one-year low of $52.88. NUS’s market cap is $4.12B and the company has a P/E ratio of 29.56.
Based on 3 analyst ratings, the analyst consensus is Moderate Buy with an average price target of $79.67, reflecting a -5.2% downside.
The insider sentiment on Nu Skin has been negative according to 56 insider trades in the past three months. This sentiment is lower than the average sentiment of company insiders in this sector.
Company insider trades are published daily on the SEC (Securities and Exchange Commission). DailyInsider’s proprietary algorithm analyzes these trades and selects the most attractive stocks based on influential insider trades each day. To subscribe to the DailyInsider visit this page.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Nu Skin Enterprises, Inc. engages in the development and distribution of beauty and wellness products and solutions. It operates through the following geographical segments: Mainland China, Hong Kong and Taiwan, South Korea, Japan, South Asia and Pacific, Americas, and EMEA (Europe, the Middle East, and Africa.
